Product Information

BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE is a generic product labeled by NorthStar Rx LLC, priced at $0.3355 per EA under NDC 16714017001. Its NADAC has been published 270 times since May 5, 2021.

FDA first approved this application on Jul 1, 2020. Its Orange Book therapeutic-equivalence code is AA.

BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE

Butalbital, Acetaminophen, and Caffeine
$0.3355per EA
DEA Schedule CIII

Strength

300; 50; 40 mg/1; mg/1; mg/1

Manufacturer

NorthStar Rx LLC

NDC

16714017001

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

6/17/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA213046

FDA Approved

7/1/2020

TE Code

AA

On Market Since

7/1/2020

Pharmacological Classes

Barbiturate
Barbiturates
Central Nervous System Stimulant
Central Nervous System Stimulation
Methylxanthine
Xanthines

Price Statistics

The NADAC for BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE has been published 270 times since May 5, 2021, and over the history we have for it it has declined 57.6%. The table below summarizes its recorded NADAC range and movement.

Current price$0.3355 per EA
All-time high$0.9560 (Apr 12, 2023)
All-time low$0.3110 (Apr 22, 2026)
52-week high$0.3471
52-week low$0.3110
Median price$0.5649
Average price$0.5493
Largest weekly change+34.5% (Jun 19, 2024)
Weeks tracked270
Tracking sinceMay 5, 2021

Price History

1W

N/A

1M

N/A

3M

N/A

6M

+1.2%

1Y

-2.1%

3Y

-43.9%

5Y

-48.0%

All

-57.6%

Last surveyed Jul 1, 2026 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE, manufactured by NorthStar Rx LLC, is $0.3355 per EA (NDC 16714017001), effective Jul 1, 2026.

How has the price of BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE has declined 57.6%. It has been tracked across 270 weekly CMS publications since May 5, 2021.

What are the highest and lowest recorded NADAC prices for BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE?

Since May 5, 2021, the NADAC for BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE has ranged from a low of $0.3110 (Apr 22, 2026) to a high of $0.9560 (Apr 12, 2023), with a median of $0.5649 per EA.

Are there cheaper alternatives to BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE in a comparable dosage form, but none are currently priced below it.

Who manufactures BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE?

BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE (NDC 16714017001) is labeled by NorthStar Rx LLC, and CMS classifies it as a generic product.